Summary: Transphobes are irresponsibly promoting the idea that trans people should be treated with ineffective antipsychotic drugs. The “evidence” they present is so weak as to be practically nonexistent. Such a claim could only be plausible to those with no knowledge whatsoever of the broad consensus of scientific research: that transitioning is the only effective treatment for gender dysphoria.
There’s a particularly odd belief that’s been popularized by transphobes over the past few years: the claim that the antipsychotic drug pimozide can treat gender dysphoria in trans people by removing their desire to transition. This idea has been promoted in videos like these describing trans people as ‘mentally ill’, some of which have several hundred thousand views:
[08:11] Also echoing the research thus stated are pharmacotherapy studies that are 20 years old that used the drug pimozide on a cross-dressing man with a strong wish to undergo a sex change. The outcome of the study, as far as I know, has never been mentioned in the mainstream media, or at least I’ve never heard about it between the cacophony of how Caitlyn Jenner is so brave and so beautiful. But, “There was an excellent response to pimozide 2 mg daily, with a cessation of both cross-dressing and the wish for sex reassignment. When, after 1 year, the dose was reduced to 1 mg daily, there was a rapid return of the cross-dressing and the wish for sex reassignment. An increase in the dose again led to a remission which has been maintained since then.” And the conclusion was that, “Pharmacotherapy with pimozide should be considered in cases of doubtful gender dysphoria.” But in all reality, this is one of those cases where you don’t really need to appeal to scientific authority, as it’s clear even enough to a layman to come to these conclusions.
Let’s connect some dots. On December 22nd, the Kansas City Star 
